Need help finding what you are looking for?
Contact Us
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1378628
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1378628
Lung Cancer Diagnostic and Screening Market, By Test Type (Biomarkers Test Imaging Test (Computed Tomography scan, Positron Emission Tomography scan, Chest X-Ray, Others), Biopsy), By Cancer Type, By End User, By Geography
PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global lung cancer diagnostic and screening market is estimated to be valued at US$ 2,458.7 million in 2023 and is expected to exhibit a CAGR of 10.1% during the forecast period (2023-2030).
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 2,458.7 Mn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 10.10% | 2030 Value Projection: | US$ 4,835.6 Mn |
Lung cancer is a disease caused by uncontrolled cell division in lungs. Cells divide and make more copies of themselves as part of their normal function. The uncontrolled division of damaged cells results in tissue tumors, which eventually prevent organs from functioning properly. Lung cancer start in the lungs, commonly in the airways (bronchi or bronchioles) or small air sacs (alveoli). Cancers that begin in another location and spread to the lungs are typically named after the location of their origin. Lung cancer treatments include surgery, radiofrequency ablation, radiation therapy, chemotherapy, targeted drug therapy, and immunotherapy. Key players in the industry are focusing on the development of technologically advanced products. Thus, the introduction of such advanced products into the market is expected to drive the growth of the global lung cancer diagnostic and screening market over the forecast period.
Market Dynamics
The key players in the industry are focusing on the development of technologically advanced equipment, instruments, and systems for various surgical procedures. Thus, the introduction of such advanced products in the market is expected to drive growth of the global lung cancer diagnostic and screening market over the forecast period. For instance, in May 2021, QIAGEN, a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research announced the launch of an expanded scope of companion diagnostic (CDx) claims for the therascreen KRAS RGQ PCR Kit (therascreen KRAS Kit) after it received U.S. regulatory approval as a companion diagnostic to aid in the identification of non-small cell lung cancer (NSCLC) patients that may be eligible for treatment.
Key features of the study:
- This report provides an in-depth analysis of the global lung cancer diagnostic and screening market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global lung cancer diagnostic and screening market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Abbott, Amgen Inc., Illumina, Inc., Thermo Fisher Scientific Inc., Lepu Medical Technology(Beijing)Co.,Ltd., AstraZeneca, F. Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings., Agilent Technologies, Inc., QIAGEN, Quest Diagnostics Incorporated., NeoGenomics Laboratories., Myriad Genetics, Inc., GRAIL, LLC., DELFI Diagnostics.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global lung cancer diagnostic and screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lung cancer diagnostic and screening market.
Global Lung Cancer Diagnostic and Screening Market Detailed Segmentation:
- By Test Type:
- Biomarkers Test
- EGFR Mutation Test
- KRAS Mutation Test
- ALK Test
- HER2 Test
- Others
- Imaging Test
- Computed Tomography (CT) scan
- Positron Emission Tomography (PET) scan
- Chest X-Ray
- Others
- Biopsy
- By Cancer Type:
- Non-small cell lung cancer
- Small Cell Lung Cancer
- By End User:
- Hospital Associated Labs
- Independent Diagnostic Laboratories
- Cancer Research Institutes
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Company Profiles
- Abbott
- Amgen Inc.,
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Lepu Medical Technology(Beijing)Co.,Ltd.
- AstraZeneca
- F.Hoffmann-La Roche Ltd
- Laboratory Corporation of America Holdings.
- Agilent Technologies, Inc.
- QIAGEN
- Quest Diagnostics Incorporated.
- NeoGenomics Laboratories.
- Myriad Genetics, Inc.
- GRAIL, LLC.
- DELFI Diagnostics.
Product Code: CMI4434
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Test Type
- Market Snippet, By Cancer Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Lung Cancer Diagnostic and Screening Market - COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Lung Cancer Diagnostic and Screening Market, By Test Type, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Biomarkers Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
- EGFR Mutation Test
- KRAS Mutation Test
- ALK Test
- HER2 Test
- Others
- Imaging Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
- Computed Tomography (CT) scan
- Positron Emission Tomography (PET) scan
- Chest X-Ray
- Others
- Biopsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
6. Global Lung Cancer Diagnostic and Screening Market, By Cancer Type, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Non-small cell lung cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
- Small Cell Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
7. Global Lung Cancer Diagnostic and Screening Market, By End User, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Hospital Associated Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Independent Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Cancer Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
8. Global Lung Cancer Diagnostic and Screening Market, By Region, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Test Type, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Test Type, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Test Type, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Test Type, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Test Type, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Test Type, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Abbott
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Amgen Inc.,
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Lepu Medical Technology(Beijing)Co.,Ltd.
- AstraZeneca
- F. Hoffmann-La Roche Ltd
- Laboratory Corporation of America Holdings.
- Agilent Technologies, Inc.
- QIAGEN
- Quest Diagnostics Incorporated.
- NeoGenomics Laboratories.
- Myriad Genetics, Inc.
- GRAIL, LLC.
- DELFI Diagnostics
10. Section
- References
- Research Methodology
- About us and Sales Contact
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.